Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH)
Health Care · Pharmaceuticals · MY
RM1.96
+1.55% today · -9.3% 1Y
Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $68.04M.
Over the last twelve months the share price has lost 9.3%, trading between 1.91 and 2.20.
Tweenvest scores Y.S.P. Southeast Asia Holding Berhad across four factors: quality 81/100, value 77/100, growth 32/100, dividend 73/100. Its strongest factor is quality.
YSPSAH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $68.04M
- Revenue (TTM)
- $90.48M
- P/E
- 10.29
- EPS
- 0.19
- Dividend yield
- 5.61%
- Beta (5Y)
- -0.01
- 52-week high
- RM2.20
- 52-week low
- RM1.91
- Avg volume (3M)
- —
- Shares outstanding
- 141.84M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KOREA PHARMA Co., Ltd.KOSDAQ: A032300 | $69.53M | ₩8,570.00 | -1.72% |
| WITHUS PHARMACEUTICAL Co.,LTD.KOSDAQ: A330350 | $69.12M | ₩7,040.00 | -2.90% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $69.10M | $2.90 | +4.32% |
| Syngen Biotech Co.,Ltd.TPEX: 8279 | $68.57M | NT$80.90 | +1.76% |
| Valiant Laboratories LimitedNSEI: VALIANTLAB | $67.23M | Rs119.80 | -4.22% |
| Johnson Chemical Pharmaceutical Works Co., Ltd.TPEX: 4747 | $66.40M | NT$23.35 | +1.74% |
| Wakamoto Pharmaceutical Co.,Ltd.TSE: 4512 | $66.14M | ¥301.00 | +3.44% |
| Kukje Pharma Co., Ltd.KOSE: A002720 | $64.68M | ₩4,270.00 | +30.18% |
Figures last refreshed Oct 11, 2026.